<p>miR-34c Targets MET to Improve the Anti-Tumor Effect of Cisplatin on Ovarian Cancer</p>Shiying Yang(People’s Hospital of Rizhao), Rui Luo(Linyi People's Hospital)OncoTargets and TherapyApril 1, 202010.2147/ott.s239425Cited by 13SaveCiteExport RISWatch citationsRelated PapersSafety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study|Journal of Hepatology|2021|101